Pacific Hospital Supply Co Ltd (4126) - Net Assets
Based on the latest financial reports, Pacific Hospital Supply Co Ltd (4126) has net assets worth NT$2.97 Billion TWD (≈ $93.49 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$3.92 Billion ≈ $123.48 Million USD) and total liabilities (NT$951.83 Million ≈ $29.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore 4126 total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$2.97 Billion |
| % of Total Assets | 75.71% |
| Annual Growth Rate | 6.43% |
| 5-Year Change | 9.68% |
| 10-Year Change | 35.5% |
| Growth Volatility | 5.59 |
Pacific Hospital Supply Co Ltd - Net Assets Trend (2009–2025)
This chart illustrates how Pacific Hospital Supply Co Ltd's net assets have evolved over time, based on quarterly financial data. Check 4126 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Pacific Hospital Supply Co Ltd (2009–2025)
The table below shows the annual net assets of Pacific Hospital Supply Co Ltd from 2009 to 2025. For live valuation and market cap data, see Pacific Hospital Supply Co Ltd market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | NT$2.97 Billion ≈ $93.49 Million |
+0.86% |
| 2024-12-31 | NT$2.94 Billion ≈ $92.70 Million |
+3.84% |
| 2023-12-31 | NT$2.83 Billion ≈ $89.27 Million |
+4.30% |
| 2022-12-31 | NT$2.72 Billion ≈ $85.59 Million |
+0.42% |
| 2021-12-31 | NT$2.71 Billion ≈ $85.24 Million |
+3.50% |
| 2020-12-31 | NT$2.61 Billion ≈ $82.36 Million |
+2.44% |
| 2019-12-31 | NT$2.55 Billion ≈ $80.40 Million |
+10.41% |
| 2018-12-31 | NT$2.31 Billion ≈ $72.81 Million |
+2.25% |
| 2017-12-31 | NT$2.26 Billion ≈ $71.22 Million |
+3.22% |
| 2016-12-31 | NT$2.19 Billion ≈ $69.00 Million |
+8.29% |
| 2015-12-31 | NT$2.02 Billion ≈ $63.71 Million |
+9.73% |
| 2014-12-31 | NT$1.84 Billion ≈ $58.06 Million |
+9.51% |
| 2013-12-31 | NT$1.68 Billion ≈ $53.02 Million |
+2.48% |
| 2012-12-31 | NT$1.64 Billion ≈ $51.74 Million |
+8.80% |
| 2011-12-31 | NT$1.51 Billion ≈ $47.55 Million |
+11.90% |
| 2010-12-31 | NT$1.35 Billion ≈ $42.50 Million |
+23.12% |
| 2009-12-31 | NT$1.10 Billion ≈ $34.52 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Pacific Hospital Supply Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 14345.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$1.32 Billion | 44.65% |
| Other Components | NT$1.64 Billion | 55.35% |
| Total Equity | NT$2.97 Billion | 100.00% |
Pacific Hospital Supply Co Ltd Competitors by Market Cap
The table below lists competitors of Pacific Hospital Supply Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Groupe Partouche SA
PA:PARP
|
$173.63 Million |
|
Telecomunicações Brasileiras S.A. - TELEBRÁS
SA:TELB3
|
$173.67 Million |
|
Insight Digital Partners II Class A Ordinary Shares
NASDAQ:DYOR
|
$173.71 Million |
|
Strawberry Fields REIT LLC
NYSE MKT:STRW
|
$173.71 Million |
|
GRAPHENE MANUFACT.GROUP
F:0GF
|
$173.54 Million |
|
Kginicis Co.Ltd
KQ:035600
|
$173.53 Million |
|
D-Link (India) Limited
NSE:DLINKINDIA
|
$173.48 Million |
|
FormPipe Software AB
ST:FPIP
|
$173.44 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pacific Hospital Supply Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,942,226,000 to 2,967,439,000, a change of 25,213,000 (0.9%).
- Net income of 382,870,000 contributed positively to equity growth.
- Dividend payments of 363,000,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$382.87 Million | +12.9% |
| Dividends Paid | NT$363.00 Million | -12.23% |
| Other Changes | NT$5.34 Million | +0.18% |
| Total Change | NT$- | 0.86% |
Book Value vs Market Value Analysis
This analysis compares Pacific Hospital Supply Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.86x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.67x to 1.86x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-12-31 | NT$13.40 | NT$75.90 | x |
| 2010-12-31 | NT$16.20 | NT$75.90 | x |
| 2011-12-31 | NT$20.69 | NT$75.90 | x |
| 2012-12-31 | NT$22.51 | NT$75.90 | x |
| 2013-12-31 | NT$23.08 | NT$75.90 | x |
| 2014-12-31 | NT$25.24 | NT$75.90 | x |
| 2015-12-31 | NT$27.69 | NT$75.90 | x |
| 2016-12-31 | NT$30.02 | NT$75.90 | x |
| 2017-12-31 | NT$31.01 | NT$75.90 | x |
| 2018-12-31 | NT$31.69 | NT$75.90 | x |
| 2019-12-31 | NT$34.96 | NT$75.90 | x |
| 2020-12-31 | NT$35.82 | NT$75.90 | x |
| 2021-12-31 | NT$37.07 | NT$75.90 | x |
| 2022-12-31 | NT$37.20 | NT$75.90 | x |
| 2023-12-31 | NT$38.78 | NT$75.90 | x |
| 2024-12-31 | NT$40.53 | NT$75.90 | x |
| 2025-12-31 | NT$40.87 | NT$75.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pacific Hospital Supply Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.90%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.91%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 1.32x
- Recent ROE (12.90%) is below the historical average (14.95%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | -1.16% | -1.12% | 0.78x | 1.33x | NT$-122.27 Million |
| 2010 | 25.50% | 27.55% | 0.76x | 1.22x | NT$209.03 Million |
| 2011 | 21.42% | 24.06% | 0.76x | 1.18x | NT$172.34 Million |
| 2012 | 19.09% | 21.79% | 0.73x | 1.21x | NT$149.25 Million |
| 2013 | 19.13% | 22.29% | 0.71x | 1.20x | NT$153.61 Million |
| 2014 | 17.74% | 21.70% | 0.67x | 1.22x | NT$142.70 Million |
| 2015 | 17.37% | 21.66% | 0.61x | 1.32x | NT$149.08 Million |
| 2016 | 15.19% | 19.69% | 0.51x | 1.52x | NT$113.67 Million |
| 2017 | 10.49% | 13.67% | 0.48x | 1.61x | NT$11.05 Million |
| 2018 | 9.36% | 11.87% | 0.51x | 1.55x | NT$-14.76 Million |
| 2019 | 17.99% | 22.50% | 0.52x | 1.55x | NT$203.94 Million |
| 2020 | 12.58% | 15.14% | 0.55x | 1.51x | NT$67.32 Million |
| 2021 | 14.28% | 19.14% | 0.53x | 1.40x | NT$115.87 Million |
| 2022 | 12.20% | 15.17% | 0.60x | 1.34x | NT$59.73 Million |
| 2023 | 14.85% | 18.14% | 0.62x | 1.33x | NT$137.44 Million |
| 2024 | 15.22% | 19.10% | 0.60x | 1.32x | NT$153.62 Million |
| 2025 | 12.90% | 15.91% | 0.61x | 1.32x | NT$86.13 Million |
Industry Comparison
This section compares Pacific Hospital Supply Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,667,196,000
- Average return on equity (ROE) among peers: 15.43%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pacific Hospital Supply Co Ltd (4126) | NT$2.97 Billion | -1.16% | 0.32x | $173.61 Million |
| St.Shine Optical Co Ltd (1565) | $3.89 Billion | 41.14% | 0.59x | $146.13 Million |
| Maxigen Biotech Inc (1783) | $851.32 Million | 7.06% | 0.39x | $112.59 Million |
| SciVision Biotech Inc (1786) | $1.08 Billion | 3.72% | 0.04x | $116.46 Million |
| Bioteque (4107) | $1.62 Billion | 13.32% | 0.24x | $247.80 Million |
| Chi Sheng Chemical (4111) | $1.05 Billion | 7.76% | 0.41x | $56.27 Million |
| BenQ Medical Technology (4116) | $1.09 Billion | 6.10% | 0.54x | $54.27 Million |
| Bionime Corp (4737) | $1.09 Billion | 16.51% | 1.63x | $136.35 Million |
| Vizionfocus Inc. (4771) | $2.04 Billion | 27.62% | 1.19x | $336.64 Million |
| Formosa Optical Technology Co Ltd (5312) | $2.30 Billion | 15.61% | 0.85x | $168.03 Million |
About Pacific Hospital Supply Co Ltd
Pacific Hospital Supply Co., Ltd., together with its subsidiaries, manufactures, processes, and sells medical devices in Taiwan. The company offers tubings, bags, bottles, closed wound drainage systems, surgical suction instruments, and other products, as well as involved in construction, installation, manufacturing, and sales of equipment piping and devices for medical gases. Its products in use… Read more